IBDEI0L6 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10032,2)
 ;;=^40605
 ;;^UTILITY(U,$J,358.3,10033,0)
 ;;=360.03^^44^560^21
 ;;^UTILITY(U,$J,358.3,10033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10033,1,3,0)
 ;;=3^Chronic Endophthalmitis
 ;;^UTILITY(U,$J,358.3,10033,1,4,0)
 ;;=4^360.03
 ;;^UTILITY(U,$J,358.3,10033,2)
 ;;=^268547
 ;;^UTILITY(U,$J,358.3,10034,0)
 ;;=361.02^^44^560^76
 ;;^UTILITY(U,$J,358.3,10034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10034,1,3,0)
 ;;=3^Recent RD w/ Multiple Defects
 ;;^UTILITY(U,$J,358.3,10034,1,4,0)
 ;;=4^361.02
 ;;^UTILITY(U,$J,358.3,10034,2)
 ;;=^268587
 ;;^UTILITY(U,$J,358.3,10035,0)
 ;;=361.03^^44^560^75
 ;;^UTILITY(U,$J,358.3,10035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10035,1,3,0)
 ;;=3^Recent RD w/ Giant Tear
 ;;^UTILITY(U,$J,358.3,10035,1,4,0)
 ;;=4^361.03
 ;;^UTILITY(U,$J,358.3,10035,2)
 ;;=^268588
 ;;^UTILITY(U,$J,358.3,10036,0)
 ;;=361.04^^44^560^79
 ;;^UTILITY(U,$J,358.3,10036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10036,1,3,0)
 ;;=3^Ret Det,Partial w/ Dialysis
 ;;^UTILITY(U,$J,358.3,10036,1,4,0)
 ;;=4^361.04
 ;;^UTILITY(U,$J,358.3,10036,2)
 ;;=^268589
 ;;^UTILITY(U,$J,358.3,10037,0)
 ;;=361.12^^44^560^8
 ;;^UTILITY(U,$J,358.3,10037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10037,1,3,0)
 ;;=3^Bullous Retinoschisis
 ;;^UTILITY(U,$J,358.3,10037,1,4,0)
 ;;=4^361.12
 ;;^UTILITY(U,$J,358.3,10037,2)
 ;;=^268596
 ;;^UTILITY(U,$J,358.3,10038,0)
 ;;=361.2^^44^560^102
 ;;^UTILITY(U,$J,358.3,10038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10038,1,3,0)
 ;;=3^Uveal Effusion/SRD
 ;;^UTILITY(U,$J,358.3,10038,1,4,0)
 ;;=4^361.2
 ;;^UTILITY(U,$J,358.3,10038,2)
 ;;=^268601
 ;;^UTILITY(U,$J,358.3,10039,0)
 ;;=361.9^^44^560^83
 ;;^UTILITY(U,$J,358.3,10039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10039,1,3,0)
 ;;=3^Retinal Detachment NOS
 ;;^UTILITY(U,$J,358.3,10039,1,4,0)
 ;;=4^361.9
 ;;^UTILITY(U,$J,358.3,10039,2)
 ;;=^105529
 ;;^UTILITY(U,$J,358.3,10040,0)
 ;;=362.10^^44^560^95
 ;;^UTILITY(U,$J,358.3,10040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10040,1,3,0)
 ;;=3^Rubella Retinopathy
 ;;^UTILITY(U,$J,358.3,10040,1,4,0)
 ;;=4^362.10
 ;;^UTILITY(U,$J,358.3,10040,2)
 ;;=^12267
 ;;^UTILITY(U,$J,358.3,10041,0)
 ;;=362.12^^44^560^22
 ;;^UTILITY(U,$J,358.3,10041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10041,1,3,0)
 ;;=3^Coats' Disease
 ;;^UTILITY(U,$J,358.3,10041,1,4,0)
 ;;=4^362.12
 ;;^UTILITY(U,$J,358.3,10041,2)
 ;;=^268612
 ;;^UTILITY(U,$J,358.3,10042,0)
 ;;=362.13^^44^560^88
 ;;^UTILITY(U,$J,358.3,10042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10042,1,3,0)
 ;;=3^Retinal Vascular Changes
 ;;^UTILITY(U,$J,358.3,10042,1,4,0)
 ;;=4^362.13
 ;;^UTILITY(U,$J,358.3,10042,2)
 ;;=^268614
 ;;^UTILITY(U,$J,358.3,10043,0)
 ;;=362.14^^44^560^82
 ;;^UTILITY(U,$J,358.3,10043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10043,1,3,0)
 ;;=3^Retina Microaneurysm NOS
 ;;^UTILITY(U,$J,358.3,10043,1,4,0)
 ;;=4^362.14
 ;;^UTILITY(U,$J,358.3,10043,2)
 ;;=^268615
 ;;^UTILITY(U,$J,358.3,10044,0)
 ;;=362.17^^44^560^52
 ;;^UTILITY(U,$J,358.3,10044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10044,1,3,0)
 ;;=3^Macroaneurysm
 ;;^UTILITY(U,$J,358.3,10044,1,4,0)
 ;;=4^362.17
 ;;^UTILITY(U,$J,358.3,10044,2)
 ;;=^268617
 ;;^UTILITY(U,$J,358.3,10045,0)
 ;;=362.21^^44^560^71
 ;;^UTILITY(U,$J,358.3,10045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10045,1,3,0)
 ;;=3^Prematurity-ROP
 ;;^UTILITY(U,$J,358.3,10045,1,4,0)
 ;;=4^362.21
 ;;^UTILITY(U,$J,358.3,10045,2)
 ;;=^105733
 ;;^UTILITY(U,$J,358.3,10046,0)
 ;;=362.29^^44^560^63
 ;;^UTILITY(U,$J,358.3,10046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10046,1,3,0)
 ;;=3^Nondiabetic PR
 ;;
 ;;$END ROU IBDEI0L6
